A study of the relationship between serum sialic acid and urine microalbumin in patients of type 2 diabetes mellitus nephropathy

A study of the relationship between serum sialic acid and urine microalbumin in patients of type 2 diabetes mellitus nephropathy

Автор: Patel Darshan J., Chakrabarti Chandan, Sharma Dinesh P., Maheshwari Amit V.

Журнал: Журнал стресс-физиологии и биохимии @jspb

Статья в выпуске: 3 т.20, 2024 года.

Бесплатный доступ

Background and Aim: Laboratory assessment of sialic acid as a marker of microvascular complications can be a diagnostic tool for diabetes mellitus. Microalbumin is an established predictor of diabetic nephropathy. The study was undertaken to evaluate serum sialic acid and microalbumin levels and to correlate it with glycemic control in diabetic nephropathy patients. Material and Methods: Clinically diagnosed diabetic nephropathy patientsvisiting the medicine OPD (outdoor patient department) and NCD (Non-Communicable Disease) were selected for the study. This study included 75 subjectswith diabetes types 2 of which 44 were males and 31were females. Control includes a total of 75 out of which 49 Males and 26 females. Blood samples were analysed for the glucose, C-reactive protein, and sialic acid. Urine sample was analyzed for microalbumin and sialic acid.

Еще

Diabetes mellitus, sialic acid, serum creatinine, urine microalbumin

Короткий адрес: https://sciup.org/143182798

IDR: 143182798

Список литературы A study of the relationship between serum sialic acid and urine microalbumin in patients of type 2 diabetes mellitus nephropathy

  • Chen, J. W., Gall, M. A., Yokoyama, H., Jensen, J. S., Deckert, M., & Parving, H. H. (1996). Raised serum sialic acid concentration in NIDDM patients with and without diabetic nephropathy. Diabetes care, 19(2), 130-134.
  • Crook M. A., Pickup J. C., Lumb P. J., et al. (2001). Relationship between plasma sialic acid concentration and microvascular and macrovascular complications in type 1 diabetes. Diabetes Care, 24, 316-22.
  • Danaei, G., Finucane, M. M., Lu, Y., Singh, G. M., Cowan, M. J., Paciorek, C. J..... & Ezzati, M. (2011). National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2- 7 million participants. The lancet, 378(9785), 31-40.
  • International Diabetes Federation. IDF Diabetes Atlas. (2019) 9th ed. Brussels, Belgium: International Diabetes Federation.
  • Microalbuminuria and traditional serum biomarkers of nephropathy among diabetic patients at Mbarara regional referral Hospital in south western Uganda. Journal of diabetes research, 2019, Article ID 3534260
  • Krishnamurthy, U., Halyal, S. S., & Murthy, D. S. (2011). Serum sialic acid and microalbuminuria in non insulin dependent diabetes mellitus. Biomed Res, 22, 31-4.
  • Kumar, B. S., Khan, S. A., Baba, K. S., Satyanarayana, P. V., & Mohan, I. K. (2019) Sialic acid: an early sensitive marker improves detection of nephropathy in type-2 diabetes mellitus patients. International Journal of Clinical Biochemistry and Research, 6(2), 152-156.
  • Lee, G. (2003). End-stage renal disease in the Asian-Pacific region. Seminars in nephrology 23(1), 107114.
  • Lim, A. K. (2014). Diabetic nephropathy-complications and treatment. International journal of nephrology and renovascular disease, 361-381.
  • Mehta, S. R., Kashyap, A. S., & Das, S. (2009). Diabetes mellitus in India: The modern scourge. Medical journal armed forces India, 65(1), 50-54.
  • Mohammad, J. S., Muhammad, T. M., Ahmad, M., Riaz, M., & Umair, M. (2006). Serum Sialic acid concentration and type 2 DM. Professional Med J Dec, 13(4), 508-510.
  • Nayak B, S., & Bhaktha, G. (2005). Relationship between sialic acid and metabolic variables in Indian type 2 diabetic patients. Lipids in health and disease, 4, 1-4.
  • Nayak, B. S., & Roberts, L. (2006). Relationship between inflammatory markers, metabolic and anthropometric variables in the Caribbean type 2 diabetic patients with and without microvascular complications. Journal of Inflammation, 3, 1-7.
  • Pickup, J. C. (2004). Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabetes care, 27(3), 813-823.
  • Prajna, K., Kumar, A., Rai, S., Shetty, S. K., Rai, T., Begum, M., & Shashikala, M. D. (2013). Predictive value of serum sialic acid in type-2 diabetes mellitus and its complication (nephropathy). Journal of clinical and diagnostic research: JCDR, 7(11), 2435.
  • Sabzwari, M. J., Ahmad, M., Majeed, M. T., Riaz, M., & Umair, M. (2006). Serum sialic acid concentration and type II diabetes mellitus. The Professional Medical Journal, 13(04), 508-510.
  • Saleh Ben Hamed S.R., Pavkovic P., Metelko Z. (2002) Microalbuminuria and Diabetes mellitus. Diabetologia Croatica, 31(4):209-221.
  • Satchell, S. C., & Tooke, J. E. (2008). What is the mechanism of microalbuminuria in diabetes: a role for the glomerular endothelium?. Diabetologia, 51, 714-725.
  • Shahid, S. M., & Mahboob, T. (2006). Clinical correlation between frequent risk factors of diabetic nephropathy and serum sialic acid. International Journal of Diabetes and Metabolism, 14(3), 138142.
  • Subzwari, J. J., & Qureshi, M. A. (2012). Relationship between sialic acid and microvascular complications in type 2 diabetes mellitus.
  • Kiconco, R., Rugera, S. P., & Kiwanuka, G. N. (2019). Melidonis, A., Tournis, S., Hraklioti, S., & Hraklianou, S. Biomedica, 28(2), 130-133.
  • Vijay, V., Snehalatha, C., Shina, K., Lalitha, S., & Ramachandran, A. (1999). Familial aggregation of diabetic kidney disease in type 2 diabetes in south India. Diabetes research and clinical practice, 43(3), 167-171.
  • Wild, S., Roglic, G., Green, A., Sicree, R., & King, H. (2004). Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes care, 27(5), 1047-1053.
  • Yao, K., Ubuka, T., Masuoka, N., Kinuta, M., & Ikeda, T. (1989). Direct determination of bound sialic acids in sialoglycoproteins by acidic ninhydrin reaction. Analytical biochemistry, 179(2), 332-335.
  • Yarema, K. (2006). The sialic acid pathway in human cells. Baltimore: John Hopkins University, 149-152.
  • Yokoyama, H., Jensen, J. S., Myrup, B., Mathiesen, E. R., R0nn, B., & Deckert, T. (1996). Raised serum sialic acid concentration precedes onset of microalbuminuria in IDDM: A 10-year follow-up study. Diabetes care, 19(5), 435-440.
Еще
Статья научная
QR-код для установки приложения SciUp Наведите камеру и скачайте бесплатное приложение SciUp